Pharmaceutically acceptable phosphate-glycerol carrying bodies
AssigneeVasogen Ireland Limited
InventorsAnthony Ernest BOLTON, Arkady Mandel
Life of this patent
Estimating the term…
Abstract
This invention relates to three-dimensional synthetic and semi-synthetic compositions having biological activity, and to the uses thereof in the treatment and/or prophylaxis of various disorders in mammalian patients. More particularly it relates to preparations and uses of synthetic and semi-synthetic bodies, such as liposomes, which after introduction into the body of a patient, produce beneficial anti-inflammatory, organ protective and immune regulatory effects. The invention also relates to treatments and compositions for alleviating inflammatory and autoimmune diseases and their symptoms.
Claims18
1-17. (canceled)
A method for treating an inflammatory disorder comprising administering to a patient an effective amount of pharmaceutically acceptable bodies comprising an effective number of phosphate-glycerol groups, to inhibit and/or reduce the progression of the inflammatory disorder.
23-47. (canceled)
A method for treating an inflammatory disorder comprising administering to a mammalian patient suffering from or at risk of suffering from an inflammatory disorder an effective amount of a composition comprising pharmaceutically acceptable bodies having a size of from about 20 nm to about 500 μm, comprising on the surface thereof a plurality of phosphate-glycerol groups, or groups convertible to said phosphate-glycerol groups, such that upon administration, the progression of the inflammatory disorder is inhibited and/or reduced.
53-57. (canceled)
62-73. (canceled)
Dependencies are inferred from the claim text.